Loading Maze
Maze Therapeutics

harnessing the power of genetics to transform the lives of patients

We are committed to developing breakthrough precision medicines for common diseases with large unmet medical needs.

Dramatic advances in human genetics, variant functionalization, therapeutic discovery and development methods, coupled with traditional drug development and disease area expertise enable us to decode the genetic drivers that lead to new therapies for a wide range of serious diseases.

Our commitment to Kidney Disease

Maze Therapeutics is developing medicines designed to imitate the effects of rare, naturally occurring, protective genetic variants and help halt the progression and potentially reverse the effects of kidney disease. Our first such precision medicine program is directed against APOL1 kidney disease. Learn more about our pipeline focused on targeted treatements for chronic kidney disease here.


Our recent progress